Table 2.
Medical interventions proven to prevent cancer. RCT, randomized controlled trial.
Intervention | Target | Magnitude of reduction |
Period of time (years) |
Evidence |
---|---|---|---|---|
Aspirin | Total cancer mortality | 20% | 20 | Follow-up of eight RCTs (14) |
Aspirin | Colon cancer mortality | 40% | 20 | Five RCTs (6) and RCT in Lynch syndrome (11) |
SERMs (tamoxifen, raloxifene) | Breast cancer incidence | 40–50% | 5+ | RCT (5, 69) |
Salpingo-oophorectomy | Familial breast cancer | 50% | 3+ | Synthesis of observational data (34) |
Screening for colon cancer (sigmoidoscopy and colonoscopy) |
Colon cancer mortality | Sigmoidoscopy, 30–40% |
10 | UK RCT sigmoidoscopy (33) |
Colonoscopy, 50% | Observational data and disease modeling (70, 71) |
|||
Vaccines (HPV and hepatitis) | Cervical cancer incidence | 50–100% | 20+ | Modeling vaccination rates and persistence of protection (23) |
Liver cancer incidence | 70–100% | Observational follow-up data from universal population vaccination program at birth (22, 72) |
||
Mammography | Breast cancer mortality | 30% | 10–20 | RCT and modeling (73, 74) |
Spiral computed tomography for lung cancer |
Lung cancer mortality | 20% | 6+ | RCT (75) |